Showing 1 - 2 results of 2 for search 'Zinaida Y. Mutovina', query time: 0.02s Refine Results
  1. 1
    Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study

    Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the... by Marina S. Lebedkina, Daria S. Fomina, Zinaida Y. Mutovina, Ulyana A. Mаrkina, Pavel O. Bogomolov, Vladimir P. Chulanov, Mariana A. Lysenko, Ekaterina I. Alexeeva

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study.

    Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study. by Ekaterina A Bryushkova, Valeria D Skatova, Zinaida Y Mutovina, Alena I Zagrebneva, Daria S Fomina, Tatyana S Kruglova, Anna A Akopyan, Irina D Strazhesko, Sergey A Lukyanov, Olga N Tkacheva, Maryana A Lysenko, Dmitry M Chudakov

    Published 2022-01-01
    Get full text
    Article

Search Tools: